Trial Profile

PrEP Adherence Monitoring Using Dried Blood Spots

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
Indications HIV infections
Focus Pharmacokinetics; Therapeutic Use
Acronyms DOT-DBS

Most Recent Events

02 Sep 2021 Results of two studies (DOT-DBS and TAF-DBS) assessing to mimic low, medium, and high adherence, published in the AIDS.
24 Sep 2018 Results published in the AIDS.
12 Jul 2018 Results evaluating whether tenofovir hair concentrations differ between women and men receiving directly-observed TDF/FTC published in the AIDS

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com